Table 2.
Literature review of recent series on CCK-type implants
| Author | Cases | Follow-up (years) | KSKS (mean) | KSFS (mean) | Survival rate | Causes of failure (implant removal) | Type of prosthesis | HKA (mean, °) | Radiolucent lines > 1 mm |
|---|---|---|---|---|---|---|---|---|---|
| Nakano et al. (23) | 41 | 4.1 | 82.9 | 79.2 | 97.5% | 1 infection | LCCK | 174.9 | Not reported |
| Kim YH et al. (21) | 114 | 7.2 | 90 | 64 | 96% | 3 aseptic loosening and 2 infections | LCCK | 174.5 | 4% |
| Lee JK et al. (22) | 79 | 5.3 | 88.8 | 73.4 | 93% | 4 infections and 1 aseptic loosening | LCCK | 174 | 41% |
| Hwang SC et al. (20) | 15 | 2.4 | 81 | 85 | 100% | None | LCCK | 176.9 | 18% |
| Cholewinski et al. (33) | 43 | 11 | 90 | 61 | 88.5 % | 2 infections and 1 instability | LCCK | 179.5 | 50% |
| Kwon KT et al. (34) | 18 | 6.7 | 84.8 | 63.6 | 94.5% | 1 infection | LCCK | 5 valgus | 27.8% |
| Ye CY et al. (24) | 47 | 5.5 | 80 | 85 | 95% | 2 infections | LCCK | Not reported | 4% |
| Morris MJ et al. (12) | 101 | 1 | 78 | 48.4 | 96% | 1 aseptic loosening, 3 infections | Vanguard 360 | Not reported | 4% |
| Peters CL et al. (17) | 184 | 4 | 85 | 82 | 92% | 2 aseptic loosening and 13 infections | Maxim and Vanguard SSK | Not reported | 7% |
| Lackey WG et al. (18) | 297 | 4.8 | 77.4 | 66.3 | 92.6% | 12 infections, 3 aseptic loosening, 7 other causes | Vanguard SSK | Not reported | Not reported |
| Crawford DA et al. (19) | 278 | 6 | 78.6 | 54.5 | 84% | 25 aseptic loosening, 10 infections | Vanguard SSK | Not reported | 3.9% |
| Current study | 19 | 2.7 | 76 | 65 | 63.1% | 7 aseptic loosening | Vanguard 360 | 179 | 42% |